Expression of Soluble Form of Aurora A as a Predictive Factor for Neoadjuvant Therapy in Breast Cancer Patients: A Single-Center Pilot Study.

Paweł WinterMalgorzata FuksiewiczAgnieszka Jagiello-GruszfeldZbigniew NoweckiBeata Kotowicz

Published in: Cancers (2023)

We showed that in a biologically heterogeneous group of BC patients, the pretreatment serum Aurora A levels were of significant value in predicting the response to NAT.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
rectal cancer
lymph node
prognostic factors
long non coding rna
binding protein
cell therapy